[20210326]LSB10587_最高法院的裁决揭示了国家监管医疗费用的权力 .pdf

上传人:任我行 文档编号:30503 上传时间:2022-06-24 发布时间:2021-03-26 格式:PDF 页数:4 大小:750.18KB
下载 相关 举报
[20210326]LSB10587_最高法院的裁决揭示了国家监管医疗费用的权力 .pdf_第1页
第1页 / 共4页
[20210326]LSB10587_最高法院的裁决揭示了国家监管医疗费用的权力 .pdf_第2页
第2页 / 共4页
[20210326]LSB10587_最高法院的裁决揭示了国家监管医疗费用的权力 .pdf_第3页
第3页 / 共4页
[20210326]LSB10587_最高法院的裁决揭示了国家监管医疗费用的权力 .pdf_第4页
第4页 / 共4页
亲,该文档总共4页,全部预览完了,如果喜欢就下载吧!
资源描述

1、CRS Legal Sidebar Prepared for Members and Committees of Congress Legal SidebarLegal Sidebari i Supreme Court Decision Sheds Light on State Authority to Regulate Health Care Costs March 26, 2021 Alongside recent federal efforts to combat escalating prescription drug costs, state governments have sou

2、ght to address these high costs within their borders. Many state efforts involve restrictions on pharmacy benefit managers (PBMs), companies that facilitate the purchase of drugs through the pharmaceutical distribution chain and administer prescription drug coverage on behalf of health insurers, emp

3、loyers, and others. While many states have enacted legislative measures intended to hold PBMs accountable for their role in the pharmaceutical marketplace, PBMs have challenged some of these measures on the basis that they are preempted by the federal Employee Retirement Income Security Act (ERISA).

4、 On December 10, 2020, in Rutledge v. Pharmaceutical Care Management Assn, the Supreme Court weighed in on this issue, concluding that a state PBM law withstood preemption by the federal act. Why does this case warrant attention for the Biden Administration and the 117th Congress? In the past, court

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 法规条令 > CRS 美国国会研究处报告